NCT01352962 2026-04-14Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsNational Institutes of Health Clinical Center (CC)Phase 1 Completed18 enrolled
NCT04940299 2026-03-06Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting35 enrolled
NCT02443324 2024-07-31A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract CancerEli Lilly and CompanyPhase 1 Completed175 enrolled 23 charts
NCT03590054 2024-03-22Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesUniversity of California, San FranciscoPhase 1 Completed35 enrolled
NCT01846520 2020-01-23Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersCity of Hope Medical CenterPhase NA Completed200 enrolled